| Biochemical evidence that patched is the Hedgehog receptor V Marigo, RA Davey, Y Zuo, JM Cunningham, CJ Tabin Nature 384 (6605), 176-179, 1996 | 1087 | 1996 |
| Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment Y Sakurai, AA Kolokoltsov, CC Chen, MW Tidwell, WE Bauta, ... Science 347 (6225), 995-998, 2015 | 616 | 2015 |
| Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes MF Saeed, AA Kolokoltsov, T Albrecht, RA Davey PLoS pathogens 6 (9), e1001110, 2010 | 521 | 2010 |
| Network medicine framework for identifying drug-repurposing opportunities for COVID-19 D Morselli Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, ... Proceedings of the National Academy of Sciences 118 (19), e2025581118, 2021 | 491 | 2021 |
| T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus AS Kondratowicz, NJ Lennemann, PL Sinn, RA Davey, CL Hunt, ... Proceedings of the National Academy of Sciences 108 (20), 8426-8431, 2011 | 465 | 2011 |
| Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry S Moller-Tank, AS Kondratowicz, RA Davey, PD Rennert, W Maury Journal of virology 87 (15), 8327-8341, 2013 | 303 | 2013 |
| Evaluation of Ebola virus inhibitors for drug repurposing PB Madrid, RG Panchal, TK Warren, AC Shurtleff, AN Endsley, CE Green, ... ACS infectious diseases 1 (7), 317-326, 2015 | 286 | 2015 |
| A systematic screen of FDA-approved drugs for inhibitors of biological threat agents PB Madrid, S Chopra, ID Manger, L Gilfillan, TR Keepers, AC Shurtleff, ... PloS one 8 (4), e60579, 2013 | 280 | 2013 |
| Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution D Fass, RA Davey, CA Hamson, PS Kim, JM Cunningham, JM Berger Science 277 (5332), 1662-1666, 1997 | 280 | 1997 |
| Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus MF Saeed, AA Kolokoltsov, AN Freiberg, MR Holbrook, RA Davey PLoS pathogens 4 (8), e1000141, 2008 | 231 | 2008 |
| The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus CL Hunt, AA Kolokoltsov, RA Davey, W Maury Journal of virology 85 (1), 334-347, 2011 | 201 | 2011 |
| Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates KE Pascal, D Dudgeon, JC Trefry, M Anantpadma, Y Sakurai, CD Murin, ... The Journal of infectious diseases 218 (suppl_5), S612-S626, 2018 | 176 | 2018 |
| An intrinsically disordered peptide from Ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein-RNA interactions DW Leung, D Borek, P Luthra, JM Binning, M Anantpadma, G Liu, ... Cell reports 11 (3), 376-389, 2015 | 170 | 2015 |
| Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection ME Miller, S Adhikary, AA Kolokoltsov, RA Davey Journal of virology 86 (14), 7473-7483, 2012 | 158 | 2012 |
| Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus AA Kolokoltsov, D Deniger, EH Fleming, NJ Roberts Jr, JM Karpilow, ... Journal of virology 81 (14), 7786-7800, 2007 | 153 | 2007 |
| Protein interaction mapping identifies RBBP6 as a negative regulator of Ebola virus replication J Batra, JF Hultquist, D Liu, O Shtanko, J Von Dollen, L Satkamp, ... Cell 175 (7), 1917-1930. e13, 2018 | 147 | 2018 |
| Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae JH Kuhn, Y Bao, S Bavari, S Becker, S Bradfute, JR Brister, AA Bukreyev, ... Archives of virology 158, 301-311, 2013 | 132 | 2013 |
| The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In Vitro T Lane, M Anantpadma, JS Freundlich, RA Davey, PB Madrid, S Ekins Pharmaceutical research 36, 1-6, 2019 | 115 | 2019 |
| Interferon-γ inhibits Ebola virus infection BA Rhein, LS Powers, K Rogers, M Anantpadma, BK Singh, Y Sakurai, ... PLoS pathogens 11 (11), e1005263, 2015 | 106 | 2015 |
| Actionable cytopathogenic host responses of human alveolar type 2 cells to SARS-CoV-2 RM Hekman, AJ Hume, RK Goel, KM Abo, J Huang, BC Blum, RB Werder, ... Molecular cell 80 (6), 1104-1122. e9, 2020 | 105 | 2020 |
manu anantpadmaIntegrated Research Facility, National Institute of Allergy and Infectious Diseases (NIAID)ایمیل تأیید شده در nih.gov